Hydralazine Hydrochloride Tablet
Product Images NDC 43353-205

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 43353-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100mg (43353 0205 05)

Bottle Label 100mg (43353 0205 05)
Label for Hydralazine HCl 100 mg oral tablets, containing 4200 tablets. Manufactured by Invagen Pharmaceuticals Inc., Hauppauge, NY, and repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. Includes storage instructions to keep between 20-25°C and warns to keep out of reach of children. Marked for prescription use only.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Hydralazine Structure)

Chemical Structure (Hydralazine Structure)
Chemical structure of Hydralazine Hydrochloride (C8H8N4•HCl) showing its molecular arrangement including a benzene ring and linked hydrazine group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.